Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1003843-30-8 | MDL No. : | MFCD12406890 |
Formula : | C14H25NO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PRRQDRLRMZGMRO-PHIMTYICSA-N |
M.W : | 255.35 | Pubchem ID : | 51900972 |
Synonyms : |
|
Num. heavy atoms : | 18 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.86 |
Num. rotatable bonds : | 5 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 76.02 |
TPSA : | 46.61 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.09 cm/s |
Log Po/w (iLOGP) : | 3.03 |
Log Po/w (XLOGP3) : | 2.49 |
Log Po/w (WLOGP) : | 2.76 |
Log Po/w (MLOGP) : | 1.86 |
Log Po/w (SILICOS-IT) : | 2.12 |
Consensus Log Po/w : | 2.45 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.66 |
Solubility : | 0.556 mg/ml ; 0.00218 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.11 |
Solubility : | 0.196 mg/ml ; 0.000769 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.52 |
Solubility : | 0.771 mg/ml ; 0.00302 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 3.19 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 1005397-64-7 ]
cis-tert-Butyl 2,6-dimethyl-4-oxopiperidine-1-carboxylate
Similarity: 1.00
[ 604010-24-4 ]
tert-Butyl 2,6-dimethyl-4-oxopiperidine-1-carboxylate
Similarity: 1.00
[ 1268816-80-3 ]
tert-Butyl (2S,6S)-2,6-dimethyl-4-oxopiperidine-1-carboxylate
Similarity: 1.00
[ 1148130-16-8 ]
tert-Butyl 2,6-diethyl-4-oxopiperidine-1-carboxylate
Similarity: 1.00
[ 1245643-80-4 ]
tert-Butyl 4-oxo-2-propylpiperidine-1-carboxylate
Similarity: 1.00
[ 1005397-64-7 ]
cis-tert-Butyl 2,6-dimethyl-4-oxopiperidine-1-carboxylate
Similarity: 1.00
[ 1268816-80-3 ]
tert-Butyl (2S,6S)-2,6-dimethyl-4-oxopiperidine-1-carboxylate
Similarity: 1.00
[ 1148130-16-8 ]
tert-Butyl 2,6-diethyl-4-oxopiperidine-1-carboxylate
Similarity: 1.00
[ 1245643-80-4 ]
tert-Butyl 4-oxo-2-propylpiperidine-1-carboxylate
Similarity: 1.00
[ 919119-03-2 ]
tert-Butyl 2-butyl-4-oxopiperidine-1-carboxylate
Similarity: 1.00
[ 185099-67-6 ]
tert-Butyl 3-oxo-8-azabicyclo[3.2.1]octane-8-carboxylate
Similarity: 0.98
[ 346593-03-1 ]
tert-Butyl 2,2-dimethyl-4-oxopiperidine-1-carboxylate
Similarity: 0.96
[ 188975-88-4 ]
tert-Butyl 4-oxoazepane-1-carboxylate
Similarity: 0.94
[ 873924-08-4 ]
tert-Butyl 9-oxo-3-azaspiro[5.5]undecane-3-carboxylate
Similarity: 0.92
[ 1005397-64-7 ]
cis-tert-Butyl 2,6-dimethyl-4-oxopiperidine-1-carboxylate
Similarity: 1.00
[ 1268816-80-3 ]
tert-Butyl (2S,6S)-2,6-dimethyl-4-oxopiperidine-1-carboxylate
Similarity: 1.00
[ 1148130-16-8 ]
tert-Butyl 2,6-diethyl-4-oxopiperidine-1-carboxylate
Similarity: 1.00
[ 1245643-80-4 ]
tert-Butyl 4-oxo-2-propylpiperidine-1-carboxylate
Similarity: 1.00
[ N/A ]
(2R,6S)-tert-Butyl 2,6-dimethyl-4-oxopiperidine-1-carboxylate
Similarity: 1.00